Business Model Breakdown
How CareCloud Inc Makes Money
CCLD
Market Cap
$130M
Annual Revenue
$130M
Profit Margin
8.5%
Employees
3,650
The Short Version
CareCloud Inc. provides cloud-based software and tech-enabled services designed to modernize and optimize healthcare operations for physician practices, hospitals, and other healthcare organizations. The company helps its customers manage patient records, streamline administrative tasks, and most importantly, improve their financial health through efficient billing, claims processing, and denial management using advanced, often AI-enabled, revenue cycle management (RCM) solutions. This allows healthcare providers to focus more on patient care and less on complex back-office functions.
Where the Revenue Comes From
Subscription fees for cloud-based software (EHR, Practice Management)
Revenue Cycle Management (RCM) services (fee-for-service or percentage of collections)
Professional services and implementation support
Who buys: Primarily small to mid-sized physician practices, with growing presence in larger healthcare organizations and hospitals.
Why It Works (Competitive Advantages)
- ✔Strong reputation and established presence among mid-size healthcare practices
- ✔Structured denial management workflows and transparent reporting dashboards
- ✔Strategic focus on AI-enabled revenue cycle management (RCM) solutions
- ✔Growth-by-acquisition strategy to expand service offerings and customer base
Economic Moat: Narrow (Switching Costs, Intangible Assets/IP)
What Our Analysis Says
DVR Score as of April 18, 2026
CareCloud Inc. (CCLD) has significantly strengthened its position since the last analysis, validating its turnaround narrative. The company reported a substantial beat on Q4 2025 revenue and EPS, achieving its first full-year positive EPS in 2025. Critically, strong positive operating and free cash flow are forecasted for 2026 and 2027, signaling a healthier financial trajectory. A new $50M credit facility bolsters liquidity, and a recent strategic partnership demonstrates execution on AI-enabled revenue cycle management. Valuation multiples remain below sector averages, suggesting undervaluation for a company with forecasted high EPS growth (45.5% per annum). While past dilution and acquisition-driven growth remain considerations, the clearer path to self-sustaining profitability and organic growth efforts through AI initiatives significantly de-risk the investment, supporting enhanced upside potential. The company's strategic positioning in the high-growth healthcare IT sector, coupled with improving fundamentals, underpins the elevated score and increased confidence in its 10x growth potential within 3-5 years.